Cannabis: harmful and therapeutic effects

Cannabis use is permitted in some states. In other countries, including France, cannabis remains an illegal drug, even though the topic of legalization of this drug regularly provokes heated debate.

Because if cannabis undeniably has certain properties that can be used for therapeutic purposes, we must not neglect its negative effects and potentially harmful to our body.

Here are the main effects of cannabis in the short and long term.

The effect of cannabis

Cannabis use classically causes, after a few minutes, a state of euphoria and well-being, of appeasement.
It helps with relaxation, facilitates introspection and communication.

Another effect of cannabis: the increase of auditory and visual perception . It also allows a particular perception of music.


The most common acute complication is generalized anxiety, or the appearance of real panic attack or "bad trip" following the consumption of the product.

At the somatic level, cannabis causes:

  • first an acceleration of the heart rate (tachycardia),
  • dry mouth,
  • nausea, followed later by
  • drowsiness.

Variable psychotropic effects

The psychotropic effects of cannabis will vary according to:

  • the mode of consumption (smoked, swallowed, inhaled, ..),
  • the amount of active ingredient,
  • the physical or psychic state of the consumer, and
  • his personal or family psychiatric history.

Many psychotic disorders have been described, including the occurrence of genuine acute delirious bouts, usually short-term and spontaneously resolving. The appearance of delusions but also visual hallucinations are common.

No, cannabis does not make you creative ...

... On the contrary: cannabis would make LESS creative and less intelligent. This is what comes out of a study conducted by a psychologist. Learn more ...

The therapeutic face of cannabis

As a drug, this drug helps fight against nausea and vomiting during chemotherapy.

It is also an analgesic used in certain neurological pathologies such as multiple sclerosis.

In terminally ill patients, the plant may be offered in herbal teas or by inhalation of vapors.
The active ingredient released:

  • is relaxing,
  • it facilitates sleep,
  • it's a pain killer,
  • an antispasmodic,
  • he is also an anti-emetic.
Many clinical studies are underway to validate its effects and to be able to use cannabis in the best way.

In France, SATIVEX, a cannabis-based therapeutic spray, has received a marketing authorization for people with multiple sclerosis since 2015, but has not yet been marketed for the time being. between the laboratory and the authorities on its refund price.

Want to react, share your experience or ask a question? See you in our FORUM Dependencies: alcohol, cannabis, etc. or A doctor answers you!

Read also :

> Drugs, alcohol ... the concerns of teens
> Addictions: how to get out?
> Smoking: assess your level of dependence

Popular Posts

Category Psychology, Next Article

Stress at work: how to avoid it? - Psychology

Stress at work: how to avoid it?

"It's like a Monday! "... Who has not heard, at least once in his professional life, this unhappy reflection? Stress at work is a reality for thousands of employees in France. Understanding the sources of discomfort and learning how to manage work stress will help combat this daily poison more effectively
Read More
Avoid relapses of depression: the testimony of a patient - Psychology

Avoid relapses of depression: the testimony of a patient

Testimony of Solange, 45, who tells of her difficulties in getting out of her depressive states ... You had two episodes of depression and a suicide attempt. Can you tell us? My first depression was ten years ago. The cause, I know it: my husband left me. We had been married for ten years and I was very in love
Read More
Addictions: cannabis and cocaine - Psychology

Addictions: cannabis and cocaine

Cannabis Cannabis is by far the most abused illicit substance in France. A report by the OFDT on cannabis (**) indicates that France "is among the most consumer countries in Europe both among young adults and adolescents: France is the only country with a much higher level of use. 15% for 16 year olds
Read More